The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease

被引:164
|
作者
Cheng, Ying [1 ]
Bai, Feng [2 ]
机构
[1] Southeast Univ, Sch Med, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
来源
FRONTIERS IN NEUROSCIENCE | 2018年 / 12卷
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; tau; mitochondrial transport; mitochondrial dynamics; mitochondrial dysfunction; AXONAL-TRANSPORT DEFECTS; OXIDATIVE STRESS; PHOSPHORYLATED TAU; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; HYPERPHOSPHORYLATED TAU; SYNAPTIC DYSFUNCTION; ABNORMAL INTERACTION; MOUSE MODEL; PROTEIN-TAU;
D O I
10.3389/fnins.2018.00163
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence suggests that abnormally hyperphosphorylated tau plays a vital role in the pathogenesis of Alzheimer's disease (AD). Mitochondrial dysfunction also has a recognized role in the pathophysiology of AD. In recent years, mitochondrial dysfunction has been strongly associated with tau pathology in AD. Overexpression of hyperphosphorylated and aggregated tau appears to damage the axonal transport, leading to abnormal mitochondrial distribution. In addition, pathological tau impairs mitochondrial dynamics by regulating mitochondrial fission/fusion proteins, and further causes mitochondrial dysfunction and neuronal damage. Moreover, mitochondrial dysfunction is also involved in promoting tau pathology in AD. In this article, we evaluate the relationship between phosphorylated tau and mitochondrial dysfunction in AD.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Alzheimer's disease:: Aβ, tau and synaptic dysfunction
    LaFerla, FM
    Oddo, S
    TRENDS IN MOLECULAR MEDICINE, 2005, 11 (04) : 170 - 176
  • [2] Mitochondrial dysfunction in Alzheimer's disease
    D'Alessandro, Maria Clara Bila
    Kanaan, Salim
    Geller, Mauro
    Pratico, Domenico
    Daher, Joao Paulo Lima
    AGEING RESEARCH REVIEWS, 2025, 107
  • [3] MITOCHONDRIAL DYSFUNCTION IN ALZHEIMER'S DISEASE
    Kota, Lakshmi Narayanan
    Nayak, Rashmitha
    Paul, Pradip
    Viswanath, Biju
    Varghese, Mathew
    Jain, Sanjeev
    Purushottam, Meera
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S840 - S841
  • [4] Mitochondrial dysfunction and Alzheimer's disease
    Maruszak, Aleksandra
    Zekanowski, Cezary
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 320 - 330
  • [5] Mitochondrial dysfunction and Alzheimer's disease
    Ghosh, SS
    Miller, S
    Herrnstadt, C
    Fahy, E
    Shinobu, LA
    Galasko, D
    Thal, LJ
    Beal, MF
    Howell, N
    Parker, WD
    Davis, RE
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 59 - 66
  • [6] March separate, strike together - Role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease
    Eckert, Anne
    Nisbet, Rebecca
    Grimm, Amandine
    Goetz, Juergen
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (08): : 1258 - 1266
  • [7] Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
    Ando, Kunie
    Houben, Sarah
    Homa, Megane
    de Fisenne, Marie-Ange
    Potier, Marie-Claude
    Erneux, Christophe
    Brion, Jean-Pierre
    Leroy, Karelle
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 13
  • [8] EVALUATING THE ASSOCIATION BETWEEN MITOCHONDRIAL DYSFUNCTION AND COGNITIVE DECLINE IN ALZHEIMER'S DISEASE
    Adrien, Tamare
    Sonntag, Kai-Christian
    Cohen, Bruce
    Forester, Brent
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04): : S126 - S127
  • [9] Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease
    Cadonic, Chris
    Sabbir, Mohammad Golam
    Albensi, Benedict C.
    MOLECULAR NEUROBIOLOGY, 2016, 53 (09) : 6078 - 6090
  • [10] Metabolomics and mitochondrial dysfunction in Alzheimer's disease
    Kim, Dong Hee
    Gim, Jeong-An
    Yoon, Dahye
    Kim, Suhkmann
    Kim, Heui-Soo
    GENES & GENOMICS, 2017, 39 (03) : 295 - 300